Industry-Leading TruRhythm Algorithms

Our newest detection algorithms streamline episodes without sacrificing sensitivity

Healthcare Professionals

Reveal LINQ™

Insertable Cardiac Monitoring System

OVERVIEW

The World's Smallest, Most Accurate Insertable Cardiac Monitor1,2

The Reveal LINQ™ Insertable Cardiac Monitor is a wireless and powerfully small insertable cardiac monitor ideal for patients experiencing infrequent symptoms that require long-term monitoring or ongoing management.

Graphic with headlines showing small, simple and 3 years
AN ADVANCED MONITORING SOLUTION
Graphic showing Reveal LINQ ICM MR conditional at 1.5 and 3.0 Tesla, MyCareLink patient monitor, and CareLink network and reports
DEVICE LONGEVITY THAT OPTIMIsES DIAGNOSTIC YIELD
Graphic showing 30% Cryptogenic stroke AF diagnoses occur after 2 years, 20% Syncope diagnoses occur after 2 years, and long-term continuous data for ongoing AF management

INDICATIONS

The Reveal LINQ™ ICM is an insertable automatically-activated and patient-activated monitoring system that records subcutaneous ECG and is indicated in the following cases:

  • patients with clinical syndromes or situations at increased risk of cardiac arrhythmias.
  • patients who experience transient symptoms that may suggest a cardiac arrhythmia.

PRODUCT DETAILS

THE REVEAL LINQ™ SYSTEM ADVANTAGE

Actionable data to diagnose and treat even the most difficult-to-detect arrhythmias

Unmatched Accuracy Icon

UNMATCHED ACCURACY

Device innovations that provide leading detection accuracy

Superior Evidence Icon

SUPERIOR EVIDENCE

Clinical rigor that guides decisions across multiple conditions

Simplified Monitoring Icon

SIMPLIFIED MONITORING

Exclusive solutions that offer new freedom to focus on patients

UNMATCHED ACCURACY

Device innovations that provide leading detection accuracy

DRIVING ACCURACY EVOLUTION

Dedicated to advancing accuracy with every device generation

Reveal ICM Device Evolution

Industry-Leading TruRhythm Algorithms

Our newest detection algorithms streamline episodes without sacrificing sensitivity

Brady Pause Icon
Smart Filtering

Second sensing filter analyses rhythms for possible undersensing in Brady and Pause

AF icon
Self-learning

AF algorithm learns and adapts to patients with sinus arrhythmia

 

SUPERIOR ACCURACY IN AF DETECTION

Demonstrating superior atrial fibrillation detection accuracy through our performance results.

Advanced AF Detection

Chart of AF Burden and AF Episode depicting percentage of sensitivity and PPV for Reveal LINQ ICM and Confirm ICM

Streamlined Episode Review

Chart showing the amount of fewer false positives with Reveal LINQ with TryRhythm Detection against other products

*Disclaimer: A controlled, head-to-head study evaluating the comparative performance of these devices has not been done.

SUPERIOR EVIDENCE

Clinical rigor that guides decisions across multiple conditions

HCPs  Talking

MOST STUDIED

Evidence portfolio that includes 700+ published clinical articles and abstracts10

MOST VALIDATED

Clinical validation across cryptogenic stroke, syncope, and atrial fibrillation4,9,11

MOST UTILISED

Data leveraged by clinical societies to develop treatment guidelines across indications12,13

CRYPTOGENIC STROKE

2016 ESC Guidelines for the Management of AF12

Long-term insertable cardiac monitoring recommended for cryptogenic stroke patients to document silent AF.

CRYSTAL AF Study4

Short- and intermediate-term cardiac monitoring may miss many patients with paroxysmal AF.

84 Days Icon

is the median time to AF detection in Cryptogenic Stroke patients

88 Percent Icon

of patients who had AF would have been missed if only monitored for 30 days

SYNCOPE

2018 ESC Guidelines for the Diagnosis and Management of Syncope13

ESC Syncope Guidelines now updated with stronger recommendation for the insertable cardiac monitors (ICMs):

  • ICMs upgraded to Class I/Level A recommendation — the strongest level of clinical evidence
  • ICMs added as a Class II/Level B recommendation to diagnose unexplained  falls and epilepsy
  • Holter monitor and tilt testing revised from Class I to Class II recommendation

PICTURE Study11

Reveal ICMs demonstrated success in diagnosing patients with unexplained syncope.

38 Percent Icon

of patients experienced a recurrence within one year

78 Percent Icon

of recurrent syncope patients had a Reveal ICM guided diagnosis

ATRIAL FIBRILLATION

Reveal AF Study14

AF detection increases over time for patients at high risk for AF and stroke.

40 Percent Icon

AF detection rate at 30 months

84.5 Percent Icon

of patients with AF would have been missed if only monitored for 30 days

SIMPLIFIED MONITORING

FREEDOM TO FOCUS ON BETTER PATIENT CARE

Exclusive solutions keep you connected to your patients, while turning device data into actionable insights

Reveal LINQ Mobile Manager
APP-BASED INSERTION WORK FLOW

Reveal LINQ™ Mobile Manager

Manage device registration, activation, CareLink™ pre-enrollment and patient education — right from your tablet.

Reveal LINQ™ Mobile Manager Info >

CareLink Network Image
EFFICIENT DATA MANAGEMENT

CareLink™ Network

Move critical transmissions to the forefront and assess episodes right from the simplified Quick Look™ page.

CareLink™ Network Info >

Reveal LINQ Monitoring Service Technician
A VIRTUAL EXTENSION OF YOUR CLINICAL TEAM

FocusOn™ Triaging and Monitoring Service

Save time usually spent on non-clinically actionable data, while allowing to focus only on insights that matter and act faster, thanks to the timely prioritisation done by the FocusOn™ team.

FocusOn™ for Cardiology >

FocusOn™ for Neurology >

MANUALS AND TECHNICAL GUIDES

Access prescriber, implant, MRI, and other manuals on the Medtronic Manual Library. Search by the product name (Reveal LINQ) or model number (LNQ11). 

SPECIFICATIONS

Reveal LINQ™ LNQ11 Specifications

DESCRIPTION SPECS

Volume

1.2 cc

Dimensions

44.8 mm x 7.2 mm x 4.0 mm

Mass

2.5 g ± 0.5

Distance between electrodes

37.7 mm

MRI Compatibility

3.0 and 1.5 Tesla with no post-insertion waiting period required

Battery Longevity

Projected 3 Years2

1

ICM Size Comparison Guide. Medtronic data on file. 2019.

2

ICM Accuracy Comparison Guide. Medtronic data on file. 2019.

3

Reference the Reveal LINQ™ ICM Clinician Manual for usage parameters.

4

Sanna T, Diener HC, Passman RS, et al. Cryptogenic stroke and underlying atrial fibrillation. N Engl J Med. June 26, 2014;370(26):2478-2486.

5

Furukawa T, Maggi R, Bertolone C, Fontana D, Brignole M. Additional diagnostic value of very prolonged observation by implantable loop recorder in patients with unexplained syncope. J Cardiovasc Electrophysiol. January 2012;23(1):67-71.

6

TruRhythm Detection Algorithms. Medtronic data on file. 2017.

7

Nölker G, Mayer J, Boldt LH, et al. Performance of an Implantable Cardiac Monitor to Detect Atrial Fibrillation: Results of the DETECT AF Study. J Cardiovasc Electrophysiol. December 2016;27(12):1403-1410.

8

Biotronik BioMonitor 2 Clinical Manual. 2016.

9

Sanders P, Pürerfellner H, Pokushalov E, et al. Performance of a new atrial fibrillation detection algorithm in a miniaturized ICM: Results from the Reveal LINQ Usability Study. Heart Rhythm. July 2016;13(7):1425-1430.

10

Medtronic Reveal Publications. Medtronic data on file. 2019.

11

Edvardsson N, Frykman V, van Mechelen R, et al. Use of an implantable loop recorder to increase the diagnostic yield in unexplained syncope: results from the PICTURE registry. Europace. February 2011;13(2):262-269.

12

Kirchhof P, Benussi, S, Kotecha D, et al. 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Eur Heart J. October 7, 2016;37(38):2893-2962.

13

Brignole M, Moya A, de Lange FJ, et al. 2018 ESC Guidelines for the diagnosis and management of syncope. Eur Heart J. Published online March 19, 2018.

14

Reiffel JA, Verma A, Kowey PR, et al. High Incidence of Previously Unknown (“Silent”) Atrial Fibrillation in Patients at High Risk for Atrial Fibrillation and Stroke: Primary Results from the REVEAL AF Study. Abstract presented at Heart Rhythm Society Annual Scientific Sessions. 2017.